Hidden Hypernephroma Simulating Right Atrial Tumor

Ardekani, Rostam G.; Hunter, James A.; Thomson, Andrew

doi:10.1016/s0003-4975(10)65463-x

Cited by 24 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The need for a shunt that could drain blood from the lower extremities and portal system was obvious in the 1960s, but the first clinical trials of bypass without a pump for patients with liver disease were unsuccessful. The second report of bypass used in urologic surgery was of a patient with a right atrial tumor (56). After that, several instances were reported in which ECC was used during resection of renal cell carcinoma extending into the right atrium (57)(58)(59)(60).…”

Section: Applications In Urologic Surgerymentioning

confidence: 99%

Non-cardiac surgery applications of extracorporeal circulation

et al. 2007

View full text Add to dashboard Cite

Although the efficacy of extracorporeal circulation (ECC) is well established for open-heart surgery, application of ECC in other surgical areas has not been given much attention. Advances in the related surgical technique and anesthetic management combined with refinements in the ECC procedure itself have encouraged several institutions to use ECC for complex non-cardiac surgeries. ECC is beginning to be used for circulatory support or tissue oxygenation during surgery on the lung, brain, liver, and kidney as well as in emergency situations. With ECC, difficult and complex surgeries can be performed more safely, and the success rate of certain surgeries has been positively affected. It is important that the surgeon, anesthesiologist, and perfusionist are trained in non-cardiac surgery applications of ECC. Thus, we review here non-cardiac uses that have emerged and summarize the related procedures.

show abstract

Section: Applications In Urologic Surgerymentioning

confidence: 99%

Non-cardiac surgery applications of extracorporeal circulation

et al. 2007

View full text Add to dashboard Cite

show abstract

“…1913 fü hrte Berg [4] erstmals die Extirpation eines Nierenzellkarzinoms mit infradiaphragmalem Cavathrombus durch. Ardekani entfernte 1971 erstmals einen Tumorthrombus aus dem rechten Atrium, allerdings wurde das Nierenkarzinom in situ belassen und der Patient verstarb kurz danach an Tumorprogredienz [2]. Ardekani entfernte 1971 erstmals einen Tumorthrombus aus dem rechten Atrium, allerdings wurde das Nierenkarzinom in situ belassen und der Patient verstarb kurz danach an Tumorprogredienz [2].…”

unclassified

Nierenzellkarzinome mit V.-cava-Befall

Staehler

Brkovic

1997

Der Urologe A

View full text Add to dashboard Cite

The elaboration of new operative procedures established in the last decade has led to an improved prognosis in patients with renal cell carcinoma with vena caval extension. We report on our personal operative experience in over 100 patients and present the current analysis of 76 patients with renal carcinoma with vena caval extension seen in our institution between 1985 and 1996. Sixty-six patients underwent nephrectomy and removal of vena caval tumor thrombi. Actuarial 5-year survival for patients without metastasis was 38%. For patients with tumor stages between I and III, 5-year survival was between 40 and 50% and was not significantly related to the rostral extent of the tumor thrombus. The relatively poor outcome for patients with tumor thrombi invading the right atrium was caused by a high perioperative mortality (50%). For patients with distant metastases, medium survival time was 10.5 months, implying that radical surgery is useless in cases of distant metastases.

show abstract